Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Genetics, epigenetics, and leukemia.

Shannon K, Armstrong SA.

N Engl J Med. 2010 Dec 16;363(25):2460-1. doi: 10.1056/NEJMe1012071. Epub 2010 Nov 10. No abstract available.

PMID:
21067376
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia.

Abdel-Wahab O, Levine RL.

Blood. 2013 May 2;121(18):3563-72. doi: 10.1182/blood-2013-01-451781. Review.

PMID:
23640996
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

[DNMT3A gene mutations in acute myeloid leukemia].

Chen YM, Lu QY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Dec;19(6):1556-60. Review. Chinese.

PMID:
22169324
[PubMed - indexed for MEDLINE]
4.

Epigenetics in myeloid malignancies.

Deneberg S.

Methods Mol Biol. 2012;863:119-37. doi: 10.1007/978-1-61779-612-8_7. Review.

PMID:
22359290
[PubMed - indexed for MEDLINE]
5.

Epigenetics in AML.

Melnick AM.

Best Pract Res Clin Haematol. 2010 Dec;23(4):463-8. doi: 10.1016/j.beha.2010.09.017. Epub 2010 Nov 1. Review.

PMID:
21130408
[PubMed - indexed for MEDLINE]
6.

How do novel molecular genetic markers influence treatment decisions in acute myeloid leukemia?

Patel JP, Levine RL.

Hematology Am Soc Hematol Educ Program. 2012;2012:28-34. doi: 10.1182/asheducation-2012.1.28. Review.

PMID:
23233557
[PubMed - indexed for MEDLINE]
Free Article
7.

Cancer genetics of epigenetic genes.

Miremadi A, Oestergaard MZ, Pharoah PD, Caldas C.

Hum Mol Genet. 2007 Apr 15;16 Spec No 1:R28-49. Review.

PMID:
17613546
[PubMed - indexed for MEDLINE]
Free Article
8.

Genetic biomarkers in acute myeloid leukemia: will the promise of improving treatment outcomes be realized?

Yang J, Schiffer CA.

Expert Rev Hematol. 2012 Aug;5(4):395-407. Review.

PMID:
22992234
[PubMed - indexed for MEDLINE]
9.

Clinical implications of novel mutations in epigenetic modifiers in AML.

Abdel-Wahab O, Patel J, Levine RL.

Hematol Oncol Clin North Am. 2011 Dec;25(6):1119-33. doi: 10.1016/j.hoc.2011.09.013. Epub 2011 Oct 29. Review.

PMID:
22093580
[PubMed - indexed for MEDLINE]
10.

Acute myeloid leukemia with normal cytogenetics.

Mawad R, Estey EH.

Curr Oncol Rep. 2012 Oct;14(5):359-68. doi: 10.1007/s11912-012-0252-x. Review.

PMID:
22806102
[PubMed - indexed for MEDLINE]
11.

Molecular prognostic factors in cytogenetically normal acute myeloid leukemia.

Walker A, Marcucci G.

Expert Rev Hematol. 2012 Oct;5(5):547-58. doi: 10.1586/ehm.12.45. Review.

PMID:
23146058
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Epigenetics in acute myeloid leukemia.

Plass C, Oakes C, Blum W, Marcucci G.

Semin Oncol. 2008 Aug;35(4):378-87. doi: 10.1053/j.seminoncol.2008.04.008. Review.

PMID:
18692688
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Therapeutic epigenetics: an emerging clinical approach to hematologic malignancies.

[No authors listed]

Clin Adv Hematol Oncol. 2005 Mar;3(3 Suppl 1):1-10; quiz 11-2. Review. No abstract available.

PMID:
21438190
[PubMed - indexed for MEDLINE]
14.

Genetic and epigenetic alterations of myeloproliferative disorders.

Milosevic JD, Kralovics R.

Int J Hematol. 2013 Feb;97(2):183-97. doi: 10.1007/s12185-012-1235-2. Epub 2012 Dec 12. Review.

PMID:
23233154
[PubMed - indexed for MEDLINE]
15.

DNA methyltransferases as targets for cancer therapy.

Ghoshal K, Bai S.

Drugs Today (Barc). 2007 Jun;43(6):395-422. Review.

PMID:
17612710
[PubMed - indexed for MEDLINE]
16.

DNA methyltransferases in hematologic malignancies.

Li KK, Luo LF, Shen Y, Xu J, Chen Z, Chen SJ.

Semin Hematol. 2013 Jan;50(1):48-60. doi: 10.1053/j.seminhematol.2013.01.005. Review.

PMID:
23507483
[PubMed - indexed for MEDLINE]
17.

Interpreting new molecular genetics in myelodysplastic syndromes.

Abdel-Wahab O, Figueroa ME.

Hematology Am Soc Hematol Educ Program. 2012;2012:56-64. doi: 10.1182/asheducation-2012.1.56. Review.

PMID:
23233561
[PubMed - indexed for MEDLINE]
Free Article
18.

The value-added genome: building and maintaining genomic cytosine methylation landscapes.

Rangwala SH, Richards EJ.

Curr Opin Genet Dev. 2004 Dec;14(6):686-91. Review.

PMID:
15531165
[PubMed - indexed for MEDLINE]
19.

[Epidemiology of leukemia and MDS among atomic bomb survivors in Hiroshima and Nagasaki suggests how abnormal epigenetic regulation contributes to leukemogenesis].

Inaba T.

Rinsho Ketsueki. 2009 Oct;50(10):1548-52. Review. Japanese. No abstract available.

PMID:
19915365
[PubMed - indexed for MEDLINE]
20.

Epigenetic modifications in AML and MDS.

Mahmud M, Stebbing J.

Leuk Res. 2010 Feb;34(2):139-40. doi: 10.1016/j.leukres.2009.07.019. Epub 2009 Aug 7. Review. No abstract available.

PMID:
19665226
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk